PERLMAN ANDREW J has filed 4 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 13300 shares of Arcus Biosciences, Inc. ($RCUS) on June 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | Arcus Biosciences, Inc. | $RCUS | PERLMAN ANDREW J | Director | A | Common Stock | 13300 | $0.00 | 42,625.0000 | 105,841,422 | 45.35% | 0.01% |
| June 10, 2025 | Arcus Biosciences, Inc. | $RCUS | PERLMAN ANDREW J | Director | A | Stock Option (Right to Buy) | 38300 | $0.00 | 38,300.0000 | 105,841,422 | 9999.99% | 0.04% |
| June 6, 2024 | Arcus Biosciences, Inc. | $RCUS | PERLMAN ANDREW J | Director | A | Common Stock | 8400 | $0.00 | 29,325.0000 | 0 | 40.14% | 0.00% |
| June 6, 2024 | Arcus Biosciences, Inc. | $RCUS | PERLMAN ANDREW J | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |